Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Tech and Science > New Weight-Loss Drugs Under Scrutiny Amid Pancreas Concerns : ScienceAlert
Tech and Science

New Weight-Loss Drugs Under Scrutiny Amid Pancreas Concerns : ScienceAlert

Last updated: July 3, 2025 5:10 am
Share
New Weight-Loss Drugs Under Scrutiny Amid Pancreas Concerns : ScienceAlert
SHARE

Investigation Launched into Weight-Loss Drugs Following Reports of Pancreas Problems

Weight-loss drugs like Ozempic and Zepbound have been praised for their effectiveness in combating obesity, but recent reports of potential side effects have raised concerns among UK health regulators.

According to the BBC, hundreds of individuals have reported severe pancreas problems after using these medications, prompting the UK government to launch an investigation into the matter. Officials are particularly interested in exploring whether genetic factors may play a role in predisposing certain individuals to such adverse reactions.

It’s important to approach this news with caution and perspective. While there is no definitive evidence linking these drugs to pancreas damage, it is crucial to highlight that these medications are safe for use when prescribed and monitored by a healthcare professional.

Doctor oversight is essential when it comes to using these drugs, as obtaining them through unofficial channels can pose serious risks. Additionally, not everyone is a suitable candidate for these medications, underscoring the importance of proper medical supervision.

The Medicines and Healthcare products Regulatory Agency, in collaboration with Genomics England, is spearheading the investigation into these weight-loss drugs, collectively known as GPL-1 receptor agonists. These drugs target cells in the body that are typically activated by the natural GLP-1 hormone, which regulates blood sugar and appetite.

Pancreas organ
Issues have been reported with pancreas conditions. (Sebastian Kaulitzki/Science Photo Library/Getty Images)

These medications are divided into two categories based on their active ingredients: those containing semaglutide (such as Ozempic and Wegovy) and those containing tirzepatide (including Mounjaro and Zepbound). The latter type also targets glucose-dependent insulinotropic polypeptide (GIP) receptors in addition to GLP-1 receptors for a more potent effect.

See also  Experimental Drug Tested in Mice Repairs The Eye to Restore Vision : ScienceAlert

Recent data has revealed nearly 400 cases of acute pancreatitis associated with the use of GLP-1 drugs like Mounjaro, Wegovy, Ozempic, and liraglutide, with a significant portion linked to the tirzepatide-based drug Mounjaro.

Individuals in the UK who have experienced adverse reactions to these weight-loss and diabetes medications are encouraged to report their details on the official Yellow Card website for further investigation and potential participation in a study on GLP-1 drugs and pancreatic issues.

As with any medication, the effects of these drugs must be considered in conjunction with other factors such as existing health conditions, genetics, age, and gender. While these medications offer significant benefits, it’s essential to be aware of potential risks and seek medical guidance when using them.

“GLP-1 medicines like Ozempic and Wegovy have shown promise, but like all medications, they carry a risk of serious side effects,” stated geneticist Matt Brown from Genomics England. “We believe that genetic factors may play a role in minimizing these adverse reactions.”

TAGGED:ConcernsDrugsPancreasScienceAlertScrutinyWeightLoss
Share This Article
Twitter Email Copy Link Print
Previous Article The Spring 2026 Menswear Trends? Sarongs, Boho Tops, Short-Shorts, and—Yes—Flip-Flops The Spring 2026 Menswear Trends? Sarongs, Boho Tops, Short-Shorts, and—Yes—Flip-Flops
Next Article How To Form A Community Garden How To Form A Community Garden
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Hotter Nights after Scorching Days Threaten Heart Health and Mental Well-Being

Another effective cooling method is to place a damp cloth on your forehead or neck.…

June 18, 2025

Hamas Says Ready To Implement Ceasefire Without New Conditions

Israel's offensive has thus far killed over 41,000 Palestinians and injured 95,029 others. Cairo: The…

September 11, 2024

Freed Columbia Student to Trump: ‘I Am Not Afraid of You’

A Columbia University student, Mohsen Mahdawi, who was recently released from federal custody, delivered a…

April 30, 2025

Classroom Deal of the Day: Get This Popular Fall Read Aloud for Less Than $8

Fall is the perfect time to cozy up in the classroom with a good book,…

October 8, 2024

The National Museum of American History Collects Mariska Hargitay’s Costume From ‘Law & Order: SVU’

Mariska Hargitay has been a staple on our television screens since 1999, portraying the iconic…

September 11, 2024

You Might Also Like

Bevel raises M Series A from General Catalyst for its AI health companion
Tech and Science

Bevel raises $10M Series A from General Catalyst for its AI health companion

October 31, 2025
Red Spider Nebula Holds a Secret in Its Glowing Heart, JWST Reveals : ScienceAlert
Tech and Science

Red Spider Nebula Holds a Secret in Its Glowing Heart, JWST Reveals : ScienceAlert

October 31, 2025
Stopping breaches at machine speed demands agents, not alerts
Tech and Science

Stopping breaches at machine speed demands agents, not alerts

October 31, 2025
Trump’s Baffling Call for Resuming U.S. Nuclear Tests
Tech and Science

Trump’s Baffling Call for Resuming U.S. Nuclear Tests

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?